Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$9.24M Buy
180,305
+54,980
+44% +$2.64M 0.89% 10
2022
Q3
$5.48M Buy
125,325
+59,498
+90% +$2.89M 0.66% 18
2022
Q2
$3.45M Buy
65,827
+3,005
+5% +$153K 0.39% 49
2022
Q1
$3.25M Sell
62,822
-22,964
-27% -$1.19M 0.32% 66
2021
Q4
$5.07M Sell
85,786
-5,717
-6% -$283K 0.47% 38
2021
Q3
$3.94M Sell
91,503
-7,682
-8% -$340K 0.38% 46
2021
Q2
$3.88M Sell
99,185
-1,149
-1% -$44.7K 0.36% 51
2021
Q1
$3.63M Buy
100,334
+18,299
+22% +$650K 0.36% 45
2020
Q4
$3.02M Sell
82,035
-11,453
-12% -$420K 0.31% 57
2020
Q3
$3.25M Sell
93,488
-7,311
-7% -$256K 0.35% 47
2020
Q2
$3.13M Buy
100,799
+30,998
+44% +$1.05M 0.35% 47
2020
Q1
$703K Buy
69,801
+4,462
+7% +$152K 0.1% 304
2019
Q4
$2.43M Sell
65,339
-2,977
-4% -$106K 0.25% 114
2019
Q3
$2.33M Buy
68,316
+5,855
+9% +$213K 0.24% 117
2019
Q2
$2.57M Sell
62,461
-9,044
-13% -$359K 0.27% 90
2019
Q1
$2.88M Buy
71,505
+30,171
+73% +$1.21M 0.27% 100
2018
Q4
$1.71M Buy
+41,334
New +$1.72M 0.24% 129

Other funds holding PFE

Seeyond's PFE Position: Q4 2022 in Review

Seeyond increased its Pfizer (PFE) stake by 44% in Q4 2022, buying an estimated $2.64M and bringing the position to 180,305 shares worth $9.24M. The position accounts for 0.89% of the portfolio, ranked #10.

Seeyond first reported a position in PFE in Q4 2018 and has held it in 17 quarters since. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Seeyond held 180,305 shares of Pfizer worth $9.24M as of Q4 2022.
  • Seeyond bought 54,980 Pfizer shares in Q4 2022, an estimated $2.64M.
  • Pfizer made up 0.89% of Seeyond's portfolio in Q4 2022, its #10 holding.
  • Seeyond first reported a position in Pfizer in Q4 2018 and has held it in 17 quarters since.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.